A study conducted by Villalonga-Planells et al. provided an evidential proof of cellular senescence in GBM cell lineages after treating the cultured tissue with nutlin-3a (small molecule MDM-2 antagonist). The gene discussed is MDM2; the disease is glioblastoma.